Works matching IS 14642662 AND DT 2010 AND VI 11 AND IP 3

Results: 9

Prospective epidemiological study of the prevalence of human leukocyte antigen (HLA)-B*5701 in HIV-1-infected UK subjects.

Published in:

2010

By:

Orkin C;
Sadiq ST;
Rice L;
Jackson F;
UK EPI team

Publication type:

Journal Article

CD81 expression in peripheral blood lymphocytes before and after treatment with interferon and ribavirin in HIV/HCV coinfected patients.

Published in:

HIV Medicine, 2010, v. 11, n. 3, p. 161, doi. 10.1111/j.1468-1293.2009.00758.x

By:

Micheloud, D.;
González-Nicolás, J.;
Berenguer, J.;
Lorente, R.;
Miralles, P.;
López, J. C.;
Cosín, J.;
Catalán, P.;
Muñoz-Fernández, Ma Á.;
Resino, S.

Publication type:

Article

Risk factors for HIV transmission among heterosexual discordant couples in South India.

Published in:

HIV Medicine, 2010, v. 11, n. 3, p. 178, doi. 10.1111/j.1468-1293.2009.00760.x

By:

Kumarasamy, N.;
Venkatesh, K. K.;
Srikrishnan, A. K.;
Prasad, L.;
Balakrishnan, P.;
Thamburaj, E.;
Sharma, J.;
Solomon, S.;
Mayer, K.

Publication type:

Article

Large particle hyaluronic acid for the treatment of facial lipoatrophy in HIV-positive patients: 3-year follow-up study.

Published in:

HIV Medicine, 2010, v. 11, n. 3, p. 170, doi. 10.1111/j.1468-1293.2009.00761.x

By:

Skeie, L.;
Bugge, H.;
Negaard, A.;
Bergersen, B. M.

Publication type:

Article

Prospective epidemiological study of the prevalence of human leukocyte antigen (HLA)-B<sup>*</sup>5701 in HIV-1-infected UK subjects.

Published in:

HIV Medicine, 2010, v. 11, n. 3, p. 187, doi. 10.1111/j.1468-1293.2009.00762.x

By:

Orkin, C.;
Sadiq, S. T.;
Rice, L.;
Jackson, F.

Publication type:

Article

Implementing the number needed to harm in clinical practice: risk of myocardial infarction in HIV-1-infected patients treated with abacavir.

Published in:

HIV Medicine, 2010, v. 11, n. 3, p. 200, doi. 10.1111/j.1468-1293.2009.00763.x

By:

Kowalska, J. D.;
Kirk, O.;
Mocroft, A.;
Høj, L.;
Friis-Møller, N.;
Reiss, P.;
Weller, I.;
Lundgren, J. D.

Publication type:

Article

Trends in uptake of recently approved antiretrovirals within a national healthcare system.

Published in:

HIV Medicine, 2010, v. 11, n. 3, p. 209, doi. 10.1111/j.1468-1293.2009.00764.x

By:

Belperio, P. S.;
Mole, L. A.;
Boothroyd, D. B.;
Backus, L. I.

Publication type:

Article

Steady-state amprenavir and tenofovir pharmacokinetics after coadministration of unboosted or ritonavir-boosted fosamprenavir with tenofovir disoproxil fumarate in healthy volunteers.

Published in:

HIV Medicine, 2010, v. 11, n. 3, p. 193, doi. 10.1111/j.1468-1293.2009.00765.x

By:

Luber, A. D.;
Condoluci, D. V.;
Slowinski, P. D.;
Andrews, M.;
Olson, K.;
Peloquin, C. A.;
Pappa, K. A.;
Pakes, G. E.

Publication type:

Article

Use of a prescription-based measure of antiretroviral therapy adherence to predict viral rebound in HIV-infected individuals with viral suppression.

Published in:

HIV Medicine, 2010, v. 11, n. 3, p. 216, doi. 10.1111/j.1468-1293.2009.00771.x

By:

Cambiano, V.;
Lampe, F. C.;
Rodger, A. J.;
Smith, C. J.;
Geretti, A. M.;
Lodwick, R. K.;
Holloway, J.;
Johnson, M.;
Phillips, A. N.

Publication type:

Article